A Study to Describe Pediatric Influenza Vaccine Coverage
NCT00639418 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 147494
Last updated 2014-09-15
Summary
The purpose of this study is to describe flu vaccine coverage in children under 18 years of age and to examine correlations between in-office flu vaccine coverage and the use of various tactics to increase vaccine coverage.
Conditions
- Healthy
Interventions
- BIOLOGICAL
-
Influenza vaccination
This non-interventional study prospectively captured vaccine coverage and practices of participating physician offices through use of surveys during the influenza vaccination season.
Sponsors & Collaborators
-
MedImmune LLC
lead INDUSTRY
Principal Investigators
-
Chris Ambrose, M.D. · MedImmune LLC
Eligibility
- Min Age
- 6 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-08-31
- Primary Completion
- 2011-03-31
- Completion
- 2011-06-30
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11
NCT01206114 ·Status: COMPLETED
-
Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 Month
NCT01040078 ·Status: UNKNOWN ·Phase: PHASE3
-
Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents
NCT02387294 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics
NCT00336453 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine (an Adjuvanted Sub-unit Influenza Vaccine and a Non-adjuvanted Split Virion Influenza Vaccine) in the Previous V70P2 Study
NCT00644540 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children
NCT00972517 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children
NCT01196988 ·Status: COMPLETED ·Phase: PHASE3
-
Immunologic Response to Influenza Vaccination in Children and Adolescents
NCT03614975 ·Status: COMPLETED ·Phase: PHASE4
-
Collaborative Efforts to Increase Flu Vaccination
NCT01403649 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines
NCT00644059 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route)
NCT01138397 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years
NCT00537524 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years
NCT05313893 ·Status: COMPLETED ·Phase: PHASE4
-
Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home
NCT00812110 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
NCT01992107 ·Status: COMPLETED ·Phase: PHASE3
-
Influenza Vaccine Attitudes, Intent, and Receipt: Pediatric
NCT02907580 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults
NCT00333398 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Flu Vaccine Doses in Children
NCT01164553 ·Status: COMPLETED ·Phase: PHASE1
-
Immune Response Study of Influenza Vaccine
NCT01310374 ·Status: COMPLETED
-
Influenza Immunity in Children
NCT02559505 ·Status: COMPLETED ·Phase: NA
-
Exploration on the Quadrivalent Influenza Vaccine Immunization Schedule for Children Aged 3-8 Years
NCT06095947 ·Status: COMPLETED
-
Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu Vaccine
NCT03300050 ·Status: COMPLETED ·Phase: PHASE1
-
A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents
NCT00976469 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects
NCT01342796 ·Status: COMPLETED ·Phase: PHASE2
-
Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children
NCT01000831 ·Status: COMPLETED ·Phase: PHASE4